New Option for HER2-positive Breast Cancer First Trastuzumab-Biosimilar available

被引：0

|

作者：

Eiden, Petra

机构：

来源：

BREAST CARE | 2018年 / 13卷 / 03期

关键词：

TRIAL; CT-P6;

D O I：

10.1159/000490869

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

[No abstract available]

引用

收藏

页码：221 / 221

页数：1

相关论文

共 50 条

[1] New Option for HER2-positive Breast Cancer. First Trastuzumab Biosimilar available
Eiden, Petra
ONCOLOGY RESEARCH AND TREATMENT, 2018, 41 (7-8) : 485 - 485
[2] Trastuzumab-Biosimilar Herzuma® - a new Therapy Option for HER2-positive Breast- and Gastric Carcinoma
不详
VISCERAL MEDICINE, 2018, 34 (03) : 233 - 233
[3] Trastuzumab Biosimilar for HER2-positive Breast Cancer and Stomach Cancer Effective and economical Treatment with a new Trastuzumab Biosimilar
不详
BREAST CARE, 2019, 14 (05) : 338 - 339
[4] Trastuzumab Biosimilar for Patients with HER2-positive Breast Cancer and Stomach Cancer Effective and economical Treatment with a new Trastuzumab Biosimilar
不详
BREAST CARE, 2019, 14 (04) : 260 - 261
[5] ABP 980: promising trastuzumab biosimilar for HER2-positive breast cancer
Paplomata, Elisavet
Nahta, Rita
EXPERT OPINION ON BIOLOGICAL THERAPY, 2018, 18 (03) : 335 - 341
[6] The Global Need for a Trastuzumab Biosimilar for Patients With HER2-Positive Breast Cancer
Blackwell, Kimberly
Gligorov, Joseph
Jacobs, Ira
Twelves, Chris
CLINICAL BREAST CANCER, 2018, 18 (02) : 95 - 113
[7] Trastuzumab biosimilar for HER2-positive breast and gastric carcinoma
不详
ONCOLOGY RESEARCH AND TREATMENT, 2019, 42 (09) : 482 - 483
[8] Trastuzumab/Hyaluronidase-oysk: A New Option for Patients With HER2-Positive Breast Cancer
Duco, Marissa R.
Murdock, Joshua L.
Reeves, David J.
ANNALS OF PHARMACOTHERAPY, 2020, 54 (03) : 254 - 261
[9] Budget Impact Analysis of the Introduction of a Trastuzumab Biosimilar for HER2-Positive Breast Cancer in China
Chai, Qingqing
Wen, Haini
Lang, Yitian
Zhang, Lingyu
Song, Yan
Liu, Xiaoyan
CLINICAL DRUG INVESTIGATION, 2022, 42 (11) : 937 - 947
[10] Evaluation of Biosimilar Trastuzumab MYL-1401O in HER2-Positive Breast Cancer
Eser, Kadir
Sezer, Emel
Ercolak, Vehbi
Inal, Ali
AMERICAN JOURNAL OF MANAGED CARE, 2023, 29 (02): : E36 - +

← 1 2 3 4 5 →